22 November 2024 in Nature Microbiology
18 March 2024 in Nature Communications
DFDavid Fernandez-Martinez
+6
Type IV pili (T4P) are prevalent, polymeric surface structures in pathogenic bacteria, making them ideal targets for effective vaccines. However, bacteria have evolved efficient strategies to evade type IV pili-directed antibody responses. Neisseria meningitidis are prototypical type IV pili-expressing Gram-negative bacteria responsible for life threatening sepsis and meningitis. This species has evolved several genetic strategies to modify the surface of its type IV pili, changing pilin subunit amino acid sequence, nature of glycosylation and phosphoforms, but how these modifications affect antibody binding at the structural level is still unknown. Here, to explore this question, we determine cryo-electron microscopy (cryo-EM) structures of pili of different sequence types with sufficiently high resolution to visualize posttranslational modifications. We then generate nanobodies directed against type IV pili which alter pilus function in vitro and in vivo. Cryo-EM in combination with molecular dynamics simulation of the nanobody-pilus complexes reveals how the different types of pili surface modifications alter nanobody binding. Our findings shed light on the impressive complementarity between the different strategies used by bacteria to avoid antibody binding. Importantly, we also show that structural information can be used to make informed modifications in nanobodies as countermeasures to these immune evasion mechanisms.
23 December 2020 in Frontiers in Immunology
Achieving immunoregulation via in vivo expansion of Foxp3+ regulatory CD4+ T cells (Treg) remains challenging. We have shown that mobilization confers to multipotent hematopoietic progenitors (MPPs) the capacity to enhance Treg proliferation. Transcriptomic analysis of Tregs co-cultured with MPPs revealed enhanced expression of genes stabilizing the suppressive function of Tregs as well as the activation of IL-1β–driven pathways. Adoptive transfer of only 25,000 MPPs effectively reduced the development of experimental autoimmune encephalomyelitis (EAE), a pre-clinical model for multiple sclerosis (MS). Production of the pathogenic cytokines IL-17 and GM-CSF by spinal cord-derived CD4+ T-cells in MPP-protected recipients was reduced while Treg expansion was enhanced. Treg depletion once protection by MPPs was established, triggered disease relapse to the same level as in EAE mice without MPP injection. The key role of IL-1β was further confirmed in vivo by the lack of protection against EAE in recipients of IL-1β–deficient MPPs. Mobilized MPPs may thus be worth considering for cell therapy of MS either per se or for enrichment of HSC grafts in autologous bone marrow transplantation already implemented in patients with severe refractory multiple sclerosis.
3 April 2024 in Nature Communications
DFDavid Fernandez-Martinez
+6
, which incorrectly read 'Cyro-EM in combination with molecular dynamics simulation of the nanobody-pilus complexes reveals how the different types of pili surface modifications alter nanobody binding.' The correct version states 'Cryo-' in place of 'Cyro-'. The original version of this Article contained an error in the Introduction, which incorrectly read 'Finally, a third level of variation comes from another PTM on serine 68, phosphoforms that can be phosphocholine (PC) or phosphoethanolamine (PEA) if the pptA allele is present in the strain, or a phosphoglycerol (glycerol-3-phosphate or G3P) if the pptB allele is present.' The correct version states 'serine 69' in place of 'serine 68'. The original version of this Article contained an error in Figure 1 legend, which incorrectly read 'c. Individual pilin subunit with G3P and GATDH, the hypervariable loop appears in dark blue. Close-ups of the phosphoglycerol moiety on S69 and on the GATDH moiety present on S63 are indicated.' The correct version adds 'SB' after 'Individual'. The original version of this Article contained an error in the Results section, which incorrectly read 'In contrast, despite the minor difference between the two sugar forms, the presence of a DATDH had a strong impact on F10 binding in both assays (Fig. 3b and Fig. 7c).' The correct version states '3a' in place of '3b'. The original version of this Article contained three errors in the Methods section, which incorrectly read 'ΔG4 strain (GATDH). The pglB1 ORF without the first 23 bp was amplified with Phusion Plus DNA Polymerase (Thermo Scientific, #F630S) from MS11 chromosomal DNA using the primers pglB1_MS11_fwd and pglB1_MS11_rev.', 'GC agar plates' and '100x oil'. The correct version adds '(Supplementary Table 2)' after 'pglB1_MS11_rev.', and states 'GCB agar plates' in place of 'GC agar plates' and '40x' in place of '100x'.